BOSTON - Monday, November 5th 2012 [ME NewsWire]

Sapient EngagedNowSM Delivers Innovative Multi-Channel Customer Experiences through a Unified Platform

(BUSINESS WIRE)-- SapientNitro, part of Sapient (NASDAQ: SAPE), today announced the launch of Sapient EngagedNowSM, a robust cloud-based platform offering that gives marketers the ability to better engage today’s on-the-go consumers across an increasing array of digitally enhanced channels. With EngagedNow, brands can create immersive, multi-channel customer experiences -- without having to design, develop and support the infrastructure needed to enable these experiences.

EngagedNow is a platform suite that can be used broadly by marketers across a range of industries. The suite also includes unique offerings and modular capabilities to support the specific needs of industry verticals, including sports & entertainment (Sapient EngagedFanSM) and travel (Sapient EngagedTravelerSM). EngagedNow is the ... Read more »

TOKYO - Saturday, November 3rd 2012 [ME NewsWire]

Results were presented at the American Society of Nephrology 2012 annual "Kidney Week" meeting and published online in the New England Journal of Medicine (NEJM). The results are intended to form the basis of regulatory filings in multiple countries seeking a new drug approval in ADPKD
Investigational Phase III trial met its primary efficacy endpoint, demonstrating reductions of change in total kidney volume for subjects receiving tolvaptan compared to placebo
ADPKD is the most common inherited cause of kidney failure, accounting for about 5 percent of end-stage renal disease in the U.S. The diagnosed prevalence is estimated to be between 1:1000 and 1:4000 globally

(BUSINESS WIRE)-- Otsuka Pharmaceutical Co., Ltd. today announced that the clinical trial results for tolvaptan, an investigational drug for the treatment of ADPKD, were presented for the first time at the American Society of Nephrology ... Read more »

HIGH POINT, N.C. - Saturday, November 3rd 2012 [ME NewsWire]

(BUSINESS WIRE)-- TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents. TTP054 acts as an agonist of the glucagon-like peptide 1 receptor (GLP1r).

“Currently available anti-diabetic agents fall short in controlling diabetes in a large percentage of the affected population. Therefore, the search for novel drugs and mechanisms to address this huge unmet medical need is imperative,” said Dr. Adnan Mjalli, Chairman and CEO of TransTech Pharma. “Injectable GLP-1 analogues, have shown impressive efficacy in the treatment of type 2 diabetes but are associated with several side effects, in ... Read more »

BUSINESS WIRE / ME NewsWire MCLEAN, Va. - Thursday, November 1st 2012

Today, on World Food Day, Hilton Worldwideannounced multi-year partnerships with Feeding Americaand The Global FoodBanking Networkto secure food and reduce hunger in communities where it operates around the globe. The collaborations will enable Hilton Worldwide hotels to collect safe, surplus food from conferences and daily food and beverage operations that would otherwise be thrown away and make it available to those in need.

Feeding America and The Global FoodBanking Network will each connect Hilton Worldwide hotels with local food banks and their networks of local community agencies to facilitate food delivery to school feeding programs, food pantries, soup kitchens, hospices, after-school programs and other community programs that provide food to families in need of nourishing meals. In year one, Hilton Worldwide will pilot food donation systems in New York City, Washington, D.C., Chicag ... Read more »

NEW YORK - Thursday, November 1st 2012 [ME NewsWire]

    Transaction Values Warnaco at $2.9BN – a 34% Premium Over its Last Closing Price
    Reunites the House of "Calvin Klein” to Ensure Single Brand Vision
    PVH Will Have Established Operations in Every Major Consumer Market Worldwide
    Acquisition Enhances PVH’s Long-Term Growth and Profitability Driven by "Calvin Klein” and "Tommy Hilfiger”
    Transaction Accretive to Year One Earnings by $0.35 Per Share, Excluding One-Time and Transaction Related Costs

(BUSINESS WIRE)-- PVH Corp. (NYSE: PVH) and The Warnaco Group, Inc. (NYSE: WRC) today announced that they have entered into a definitive merger agreement pursuant to which PVH will acquire Warnaco and holders of Warnaco common stock will receive $51.75 in cash and .1822 of a share of PVH common stock for each share of Warnaco common stock. The transaction values Warnaco at appr ... Read more »

VERSAILLES, France - Thursday, November 1st 2012 [ME NewsWire]

(BUSINESS WIRE)-- Trusted Labs, a leading expert in security consulting and evaluation services, today announced it has provided the expertise to achieve a major breakthrough: the first smart card integrated circuit (IC) to obtain the highest level of internationally recognized security assurance for IT systems, the Common Criteria EAL7.

Trusted Labs supported Samsung in fulfilling the EAL7 high security requirements by mathematically verifying the secure design and developing in-depth testing methodology of the Memory Protection Unit, which is at the core of security in integrated circuits.

The EAL7 certification of the EAL5+ certified IC - Samsung flash 264Kbyte smartcard IC for finance, security ID based on 90nm technology - brings the highest assurance on the implementation of the IC’s security-critical functionalities.

Trusted Labs managed this project with a cost- and time-effective approac ... Read more »

The Netherlands - Thursday, November 1st 2012 [ME NewsWire]

EMC Momentum Europe 2012

(BUSINESS WIRE/ME NewsWire)-- euroscript is proud to announce that DSM, the global Life Sciences and Materials Sciences company, has decided to use the eDRG integrated within Documentum D2 because of its simple configuration and customization capabilities.

DSM was searching for a product that could handle all reporting needs for their Documentum system.

“We chose the eDRG for its integration in D2 Client, the ways queries are built for reports, its flexibility in defining report templates, functionalities as adhoc reports and scheduled reports and the rules to define if the final report is sent, stored or opened. Even with lots of functionality in eDRG, learning eDRG to use reports, build reports and report templates and manage them is found quite easy,” says Mark Boon, Solution Designer at DSM ICT.

“For a few years now, the euroscript De ... Read more »

BUSINESS WIRE / ME NewsWire BERTRANGE, Luxembourg - Thursday, November 1st 2012

euroscript chooses Interverbum Technology's TermWeb terminology management solution as a component of its Global Content Management solution.

This will allow euroscript to better support its modular offering of tailored terminology services and add tangible value to its customers’ terminology assets.

“Our customers recognize the value of their corporate terminology assets to strengthen their unique footprint and to streamline internal information management," says Karina Martínez Ferber, Director Processes & Technology at euroscript International S.A."Such assets need to be accessible for employees and other stakeholders and well-integrated in the content lifecycle. euroscript provides customers with the right services and tools along the entire lifecycle. Interverbum’s TermWeb will enable us to offer to our customers secured online access to their multilingual diction ... Read more »

HIGHLAND HEIGHTS, Ky. - Thursday, November 1st 2012 [ME NewsWire]

(BUSINESS WIRE)-- General Cable Corporation(NYSE: BGC), one of the most globally diversified industrial companies, reported today results for the third quarter ended September 28, 2012. Non-GAAP adjusted earnings per share of $0.60 were within management’s range of expectations. Included in this result is $0.12 per share of additional tax expense recorded in the third quarter reflecting an increase in the Company’s estimated full year effective tax rate with the cumulative adjustment of the first half of the year being reported in the third quarter as well as other incremental discrete tax items. Operating income of $75.4 million exceeded management’s range of expectations for the third quarter as operating results in the Company’s Rest of World (ROW) segment and increased submarine and land based turnkey project activity more than offset seasonal declines in many of the businesses in the Company’s North Ame ... Read more »

INGELHEIM, Germany - Wednesday, October 31st 2012 [ME NewsWire]

Presentation of RELY-ABLE® study results: First and only long-term efficacy & safety data on a novel oral anticoagulant for stroke prevention in atrial fibrillation (AF) to be announced in the Clinical Science: Special Reports session
New sub-analyses from the 18,000 patient landmark trial RE-LY® also discussed
Real-world clinical data for VTE prevention in total knee or hip replacement to be presented

(BUSINESS WIRE)-- For Non-US, Non-UK & Non-Canadian Media Only

Widely anticipated results from RELY-ABLE®, the first long-term follow-up study of a novel oral anticoagulant treatment for stroke prevention in AF, will be among the numerous clinical reports on Pradaxa® (dabigatran etexilate) to be presented at the American Heart Association’s (AHA) Scientific Sessions in Los Angeles from 3-7 November.1 The wealth of evidence being presented for Pradaxa® at this year’s AHA sh ... Read more »